Urogen Pharma Ltd. · NASDAQ:URGN
Schoenberg Mark sold 5,222 Urogen Pharma Ltd. shares (Form 4)
Traded Jun 8, 2026 · Filed Jun 9, 2026
On Jun 8, 2026, Schoenberg Mark (Chief Medical Officer) sold 5,222 Urogen Pharma Ltd. shares at US$27.30 for US$143K, leaving 139,763 shares. Filed Jun 9, 2026 (Form 4).
- Sold
- 5,222 shares
- Price
- US$27.30
- Value
- US$143K
- Holding after
- 139,763 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Ordinary Shares | Option exercise | 10,000 | 144,985 | Direct | |
| Jun 8, 2026 | Ordinary Shares | Sale | 5,222 | US$27.30 | 139,763 | Direct |
Source
Related
- Urogen Pharma Ltd.
- Schoenberg Mark
- Urogen Pharma Ltd. shareholders
- Form 4 · Schoenberg Mark · Sep 9, 2026
- Form 4 · Schoenberg Mark · Aug 24, 2026
- Form 4 · Schoenberg Mark · Jul 10, 2026
- Form 4 · Schoenberg Mark · Jun 24, 2026
- Form 4 · Schoenberg Mark · May 11, 2026
- Form 4 · Degnan Chris · Oct 9, 2026
- Form 4 · Smith Jason Drew · Sep 9, 2026
- Form 4 · Robinson James A. Jr. · Aug 28, 2026
- Form 4 · Robinson James A. Jr. · May 27, 2026